US Stock MarketDetailed Quotes

RVNC Revance Therapeutics

Watchlist
  • 4.050
  • +0.040+1.00%
Trading Jul 23 09:30 ET
423.02MMarket Cap-1103P/E (TTM)

Revance Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2024/Q1
Stock NameRevenueRatio
RHA ® Collection of dermal fillers29.57M56.94%
DaxibotulinumtoxinA-lanm (DAXXIFY ®)22.15M42.65%
Collaboration revenue217K0.42%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States234.04M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-0.90%